Table 2.
Characteristic | Median (IQR) project duration (months) | ||||
Total | Development | Execution | Writing | Submission | |
Project type | |||||
Retrospective | 17 (11–19)* | 2 (<1–4) | 2 (1–9) | 2 (1–4) | 3 (2–5) |
Prospective | 42 (24–42)* | 5 (2–8) | 20 (7–28) | 9 (2–15) | 4 (4–7) |
Bench science or other | 7 (5–24)* | 6 (<1–12) | 12 (1–23) | 1 (1–2) | 3 (<1–4) |
Regulatory approval required | |||||
No | 11 (5–19)† | <1 (<1–4) | 1 (<1–3)† | 2 (1–3) | 3 (2–5) |
Yes | 20 (17–38)† | 3 (2–5) | 7 (2–26)† | 2 (1–6) | 4 (3–5) |
External funding received | |||||
No | 16 (9–20)‡ | 2 (<1–4)‡ | 2 (1–9)‡ | 2 (1–4) | 3 (2–4)‡ |
Yes | 38 (29–58)‡ | 9 (5–12)‡ | 25 (15–27)‡ | 1 (1–12) | 7 (6–14)‡ |
Trainee participation | |||||
No | 16 (5, 24) | <1 (<1–4) | 2 (1, 7) | 3 (1, 8) | 2 (1, 4) |
Yes | 19 (11, 32) | 2 (1, 4) | 7 (2, 22) | 2 (1, 4) | 4 (3, 5) |
Prior presentation | |||||
No | 18 (10, 19) | 3 (1, 4) | 2 (1, 8)§ | 2 (1, 4) | 3 (2, 5) |
Yes | 21 (11, 40) | 2 (<1, 5) | 7 (3, 26)§ | 2 (1, 4) | 4 (3, 6) |
*Statistically significant difference across project types (p<0.05) on Kruskal-Wallis test.
†Statistically significant difference according to need for regulatory approval (p<0.05) on rank-sum test.
‡Statistically significant difference according to receipt of external funding (p<0.05) on rank-sum test.
§Statistically significant difference according to prior presentation (p<0.05) on rank-sum test.